Form 4: Dyne Therapeutics Executive Sells Shares to Cover Tax Obligations

Richard William Scalzo, SVP, Head of Finance & Admin. at Dyne Therapeutics, sold 1,390 shares of common stock to cover tax withholding obligations related to vesting restricted stock units.

Summary

• Richard William Scalzo, a senior executive at Dyne Therapeutics, sold 1,390 shares of the company's common stock on September 18, 2024.
• The sale was executed at a weighted average price of $34.55 per share, with individual transactions ranging from $34.35 to $34.70.
• This transaction was to cover tax withholding obligations related to the vesting of restricted stock units granted on September 17, 2020.
• Following the sale, Scalzo directly owns 98,568 shares, which includes 95,578 unvested RSUs.

Sentiment

Score: 5

Explanation: The document describes a routine transaction (sale of shares to cover taxes) by an executive, which is neither particularly positive nor negative.

Industry Context

Form 4 filings are a routine part of the stock market, providing transparency into the transactions of company insiders. This sale appears to be related to tax obligations, which is a common reason for such transactions.

Stakeholder Impact

• The sale of shares by an executive could have a minor negative impact on shareholder sentiment, but is unlikely to be significant given the reason for the sale.

Key Dates